© 2016 8872147 Canada Inc. or its licensors CMAJ, March 15, 2016, 188 (5) 323 and
second-line drugs. A 2012 report documented the first four patients with XXDR-TB; by 2012 …

An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died
from the disease. Although antibiotics to treat TB were developed in the 1950s and are …

42 The Journal of Association of Chest Physicians| Jul-Dec 2016| Vol 4| Issue 2 experience
with these new drugs in the country which most urgently needs to have them available [9]• …

In the early weeks of January 2012, a report of four cases of tuberculosis from Mumbai,
India, stirred up a storm. 1 India bears a giant's share of the world's multidrug-resistant …

Tuberculosis rates skyrocketing in India oping [multidrug-resistant] TB—are significantly
coming up.” WHO's new TB report suggests that multidrug-resistant TB accounts for 450 000 …

With an annual incidence of 1.9 million cases, India ranks 17th among 22 highburden
countries for TB [1]. After the directly observed treatment, short-course (DOTS) strategy was …

We recently read the editorial that was published in your journal with the title “New
treatments for Drug Resistant TB: Past imperfect, future bright” where authors did a good job …

Tuberculosis (TB) is a preventable and curable infectious disease caused by the bacteria
Mycobacterium tuberculosis. It affects the lungs but can also spread to other parts of the …

We read with interest the article by Paramasivan et al. in the June 2002 issue of the Journal,
where the authors report a low incidence of MDR-TB in the North Arcot and Raichur districts …

The continuing spread of drug-resistant tuberculosis (TB) is one of the most urgent and
difficult challenges facing global TB control. Patients who are infected with strains resistant …